health - "cancer"

The director of the University of Pittsburgh cancer Institute and UPMC cancer Centers plans to warn about 3,000 faculty and staff about the possible health risks associated with cell phone use.

Researchers at Case Western Reserve University have developed a technique that has the potential to deliver cancer-fighting drugs to diseased areas within hours, as opposed to the two days it currently takes for existing delivery systems. Using laboratory mice, drug delivery time from injection to the cancer cells was reduced from two days to mere hours. Using this as a model for potential human use, cancer patients may someday soon receive the benefits of cancer-fighting drugs within hours of injection.read more

An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70 percent to 80 percent of patients with aggressive cancers, British researchers reported Tuesday.

The St. Louis Post-Dispatch on Sunday examined the 'life-and-death' decisions pregnant women with cancer must make and the treatment options available to them. According to the Post-Dispatch, as many as one in every 1,000 pregnant women in the U.S. is diagnosed with cancer.

Patrick Swayze looks well despite his pancreatic cancer. Is it a good sign?

The earlier breast cancer is detected, the better the chance of survival. Self-exams once a month are key, even if you have regular mammograms.

Researchers at Case Western Reserve University have developed a technique that has the potential to deliver cancer-fighting drugs to diseased areas within hours, as opposed to the two days it currently takes for existing delivery systems. Using laboratory mice, drug delivery time from injection to the cancer cells was reduced from two days to mere hours.

Visualisation specialists See3D, a spin off company of the University of Aberystwyth, is developing unique, sophisticated computer-generated models that will help doctors to improve the diagnosis and treatment of prostate cancer. More than 35,000 men are diagnosed with prostate cancer each year in the UK alone and approximately 10,000 deaths per year are associated with this form of cancer.

Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, announced the presentation of positive pre-clinical animal efficacy data for its pegylated-rHuPH20 enzyme (PEGPH20) at the American Association for cancer Research (AACR) Translational cancer medicine meeting in Monterey, CA.

Rosetta Genomics, Ltd. (NASDQ: ROSG) announces that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of health Clinical Laboratory Evaluation Program.